Physician profile
Amar Chandra
NPI 1376005108
$8,640.94
in general payments reported to CMS, 2019-2025
12 companies · $1,886 in 2025
The $1,886 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,061 · 2023: $2,848 · 2024: $846 · 2025: $1,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,000 · Food and Beverage: $2,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,999.97 |
| Food and Beverage | $2,579.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cdc Medical LLC | $2,406.61 | 2022 | |
| Stryker Corporation | $1,902.28 | 2022-2025 | Salvation, Hoffmann, Flexband |
| Treace Medical Concepts, INC. | $1,899.50 | 2023-2025 | |
| Arthrex, INC. | $1,375.92 | 2023 | |
| Bioventus LLC | $279.65 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Pylant Medical | $209.19 | 2024-2025 | |
| Axogen | $140.16 | 2025 | |
| Paragon 28, INC. | $135.80 | 2025 | Portfolio |
| Smith+Nephew, INC. | $123.82 | 2024-2025 | Salto Talaris Total Ankle Prosthesis |
| Core Surgical Group | $92.42 | 2023 | |
| Medline Industries LP | $46.69 | 2025 | |
| Anika Therapeutics, INC. | $28.90 | 2024 | Tactoset |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Chandra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.